Alpine Immune Sciences Q2 EPS $(0.27) Up From $(0.60) YoY
Portfolio Pulse from Benzinga Newsdesk
Alpine Immune Sciences (NASDAQ:ALPN) reported Q2 losses of $(0.27) per share, a 55% improvement from $(0.60) per share losses in the same period last year.
August 14, 2023 | 9:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alpine Immune Sciences reported a 55% improvement in its Q2 losses per share YoY.
Alpine Immune Sciences reported a significant improvement in its Q2 losses per share compared to the same period last year. This indicates a positive financial performance, which could potentially lead to a positive impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100